Furthermore, current evidence demonstrated that the dysregulation of the Ste20 kinase pathway is closely related to malignant tumors, and TAOK1 inhibitors arrested NSCLC cells in G0/G1 phase and induced cell apoptosis, which indicates TAOK1 might play a crucial role in the pathogenesis of lung cancer [11]. Here, TAOK1 is linked to lung carcinoma.